Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03902314 · ClinicalTrials.gov registry record · Phase 4

Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy

A Phase 4 study of Tonsillar Hypertrophy and Children, Only, sponsored by Rhode Island Hospital.

Completed
Registry status
Phase 4
Development phase
70
Enrollment target
1
Study location

NCT03902314 is a Phase 4 study of Tonsillar Hypertrophy and Children, Only that has completed, run by Rhode Island Hospital. The registered enrollment target is 70 participants, below the 184-participant average among 4 other Tonsillar Hypertrophy trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03902314, a Phase 4 study of Tonsillar Hypertrophy and Children, Only, has completed, sponsored by Rhode Island Hospital.

COMPLETED
Registry status
Phase 4
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

Lidocaine is widely available and is a very commonly used local anesthetic. When administered intravenously, lidocaine infusions have anti-inflammatory effects and have significantly decreased the reliance on opioid use for adequate pain management in adult abdominal and spine surgeries. A major advantage of lidocaine infusion is that it is not associated with a significant side effect profile.The role of lidocaine in pediatric acute perioperative pain remains limited.

Interventions

  • DRUG Saline Solution
  • DRUG Lidocaine Iv

Study Locations (1)

Rhode Island

  • Hasbro Children's Hospital - Providence

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2019-05-07
Est. Completion 2021-12-06
Phase Phase 4

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT03902314

The ClinicalTrials.gov registry entry for NCT03902314 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 184-participant average among 4 other Tonsillar Hypertrophy trials with a reported enrollment target (62% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tonsillar Hypertrophy appearing as the primary indexed condition, and to 2 interventions - of which Saline Solution is the first listed.

NCT03902314 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03902314 about?

NCT03902314 is a clinical study titled "Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy". Lidocaine is widely available and is a very commonly used local anesthetic. When administered intravenously, lidocaine infusions have anti-inflammatory effects and have significantly decreased the reliance on opioid use for adequate pain management in adult abdominal and spine surgeries. A major adv...

What is the current status of trial NCT03902314?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2019-05-07. Estimated completion is 2021-12-06.

What conditions does trial NCT03902314 study?

This clinical trial studies the following conditions: Tonsillar Hypertrophy, Children, Only, Adenoid Hypertrophy.

What interventions are being tested in trial NCT03902314?

The interventions under investigation include: Saline Solution (DRUG), Lidocaine Iv (DRUG).

Who is sponsoring clinical trial NCT03902314?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03902314 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tonsillar Hypertrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.